Cleared Traditional

K212758 - Autoplaque (FDA 510(k) Clearance)

May 2023
Decision
626d
Days
Class 2
Risk

K212758 is an FDA 510(k) clearance for the Autoplaque. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Cedars-Sinai Medical Center: Aim (Los Angeles, US). The FDA issued a Cleared decision on May 19, 2023, 626 days after receiving the submission on August 31, 2021.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K212758 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 2021
Decision Date May 19, 2023
Days to Decision 626 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050